Belgium· BE-AMP-SAM012686-00

Aacifemine 2 mg

A estriol product containing estriol, registered in Belgium by Aspen Pharma Trading. The same ATC class is registered in 13 of our 19 countries.

ATC G03CA04

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedAacifemine 2 mgATCG03CA04REGISTER NO.BE-AMP-SAM012686-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Estriol is registered in 13 of 19 countries.

Countries holding a registration under ATC G03CA04 (estriol), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 8 of them publish a price we can compare per daily dose

Estriol · ATC G03CA04

13 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of estriol costs, country by country.

Normalised to the WHO defined daily dose (2 mg), the median price runs from $0.32 in France to $1.07 in Switzerland — a ×3.4 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Estriol · price per daily dose (2 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.07
  • FR France$0.32
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Estriol
Manufacturer
Aspen Pharma Trading
Country
Belgium (BE)
ATC code
G03CA04
ATC class
Estriol
Defined daily dose
2 mg, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

1 priced
  • be_apb
    0016188
    EUR 9.76
  • be_apb
    0700039

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

10 interactions on record for estriol.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Estriol · interactions on record

10 records

10 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Estriol in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All estriol products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Blissel, Estrokad
  • Cyprus · Blissel
  • Czechia · Estriol Wolff, Ovestin
  • Germany · Estriol Wolff, Oekolp
  • Denmark · Estrokad, Gelisse
  • Estonia · Ovestin
  • Spain · Blissel, Femmyn
  • Finland · Blissel, Estrokad
  • France · Blissel, Gydrelle
  • United Kingdom (Northern Ireland) · Blissel, Estriol Aspen Pharma
  • Greece · Blissel, Gelistrol
  • Croatia · Vaginelle
  • Hungary · Estriol Wolff, Estrokad
  • Ireland · Blissel, Imvaggis
  • Iceland · Ovestin
  • Italy · Atrocom, Colpogyn
  • Lithuania · Ovestin
  • Luxembourg · Aacifemine, Oekolp
  • Latvia · Ovestin
  • Malta · Ovestin
  • Netherlands · Blissel, Estriol Dr. Kade
  • Norway · Gelisse, Ovesterin
  • Poland · Blissel, Oekolp
  • Portugal · Blissel, Gelistrol
  • Romania · Ovestin
  • Sweden · Blissel, Estrokad
  • Slovakia · Estriol Wolff, Ovestin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/0dfc8b90-9790-479a-b843-78b9862a7d42
GET /v1/drugs/0dfc8b90-9790-479a-b843-78b9862a7d42?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Aacifemine 2 mg",
  "name_fr": "Aacifemine 2 mg",
  "name_nl": "Aacifemine 2 mg",
  "amp_code": "SAM012686-00",
  "strengths": [
    "2.0000"
  ],
  "pack_count": 2,
  "substances": [
    "Estriol",
    "Lactose"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Estriol",
  "authorisation_numbers": [
    "BE012686"
  ]
}

See everything about estriol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.